Madrigal Plans MASH Cirrhosis Trial With More Than 2,000 Patients for 2027

The planned Phase 3 MAESTRO-CSPH study is targeted to start in the first half of 2027, pending regulatory discussions. Madrigal expects results in the early 2030s.

Leave a Reply

Your email address will not be published. Required fields are marked *

UP NEXT

Related Tags

Loading RSS Feed

You May Like

Subscribe To Our Newsletter

Metus in ac vivamus dui id purus in risus. Nunc fringilla donec amet pulvinar vivamus suscipit. Augue porttitor eu sed proin tortor bibendum facilisis felis. Nunc egestas tellus nisl tempor aliquet malesuada ali eu sed proin tortor bibendum facilisis felis
Stay Updated by our Monthly / Weekly News Update. Zero Spamming. Terms & Condition Applied